Zimmer Biomet (TICKER: ZBH) Benchmark And Performance Data

there are 11 of samples in the benchmark for Zimmer Biomet in year 2022 in 2022. Zimmer Biomet in its benchmark peer group, had rank 9 days for days sales outstanding in 2022. Zimmer Biomet in its benchmark peer group, had rank 4 for sales growth in 2022. Zimmer Biomet in its benchmark peer group, had rank 4 for gross revenue in 2022. Zimmer Biomet in its benchmark peer group, had rank 2 for cost of goods sold as a percent of revenue in 2022. Zimmer Biomet in its benchmark peer group, had rank 11 for cash to cash cycle time in 2022. Zimmer Biomet in its benchmark peer group, had rank 11 days for days of inventory in 2022. Zimmer Biomet headquarters region is Central. Zimmer Biomet has ticker symbol ZBH. Zimmer Biomet has the following profile: Zimmer Biomet Holdings, Inc. , together with its subsidiaries, operates as a medical technology company in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S. E. T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest.. Zimmer Biomet has primary indstury Medical Devices. Zimmer Biomet had a $$11,509,000,000 gap between actual performance and next performance rank for gross revenue in competitive benchmarking in 2022. Zimmer Biomet had Abbott Laboratories, and QuidelOrtho, and Zimmer Biomet, and Edwards Lifesciences, and Bio-Rad Laboratories, and Boston Scientific, and Align Technology, and Stryker, and AdaptHealth, and Bruker, and DexCom benchmark peer companies for its SIC code in 2022. Zimmer Biomet had 9 days gap between actual performance and next performance rank for days sales outstanding in competitive benchmarking in 2022. Zimmer Biomet had 259 days gap between actual performance and next performance rank for cash to cash in competitive benchmarking in 2022. Zimmer Biomet had 229 days gap between actual performance and next performance rank for days of inventory in competitive benchmarking in 2022. Zimmer Biomet had 18,000 number of employees in 2022. Zimmer Biomet had 0.84% gap between actual performance and next performance rank for gross margin in competitive benchmarking in 2022. Zimmer Biomet had 0.06% gap between actual performance and next performance rank for sales growth in competitive benchmarking in 2022. Zimmer Biomet had 0.00% gap between actual performance and next performance rank for sales volatility in competitive benchmarking in 2022. Zimmer Biomet had 0.00% gap between actual performance and next performance rank for cost of goods sold as a percent of revenue in competitive benchmarking in 2022. Zimmer Biomet can reduce overall cost by $$712,000,000 by improving both COGS and SGA to next benchmark tier in 2022. Zimmer Biomet can reduce inventory with practices including SKU Reduction in 2022. Zimmer Biomet can reduce inventory with practices including Reduce Manufacturing Latency in 2022. Zimmer Biomet can reduce inventory with practices including Forecast Accuracy in 2022. Zimmer Biomet can reduce inventory with practices including Demand Shaping in 2022. Zimmer Biomet can reduce days sales outstanding with practices including in 2022. Zimmer Biomet can increase sales revenue by $$11,509,000,000 improving sales performance to next benchmark tier in 2022. Zimmer Biomet can increase revenue growth by $$4,000,000 by improving growth performance to next benchmark tier in 2022. Zimmer Biomet can increase overall revenue by $$11,513,000,000 by improving both growth and sales performance to next benchmark tier in 2022. Zimmer Biomet can increase days payables outstanding with practices including Strategic Sourcing in 2022. Zimmer Biomet can increase days payables outstanding by $171,000,000 days by increasing days payables outstanding to next benchmark tier in 2022. Zimmer Biomet can improve total financial performance by $$16,921,000,000 by improving revenue, costs, and working capital in 2022. Zimmer Biomet can decrease overall working capital by $$4,696,000,000 by improving inventory, payables and receivables to next benchmark tier in 2022. Zimmer Biomet can decrease inventory days by $4,354,000,000 days by reducing inventory days to next benchmark tier in 2022. Zimmer Biomet can decrease days sales outstanding by $171,000,000 days by reducing days sales outstanding to next benchmark tier in 2022. Zimmer Biomet can accelerate revenue growth practices including Revenue-optimized Planning in 2022. Zimmer Biomet can accelerate revenue growth practices including Pricing Optimization in 2022. Zimmer Biomet can accelerate revenue growth practices including Accelerate Design Pipeline in 2022. The total inventory for Zimmer Biomet was $995,300,000.00 in 2013. The total inventory for Zimmer Biomet was $2,450,700,000.00 in 2020. The total inventory for Zimmer Biomet was $2,385,000,000.00 in 2019. The total inventory for Zimmer Biomet was $2,256,500,000.00 in 2018. The total inventory for Zimmer Biomet was $2,254,100,000.00 in 2015. The total inventory for Zimmer Biomet was $2,148,000,000.00 in 2021. The total inventory for Zimmer Biomet was $2,068,300,000.00 in 2017. The total inventory for Zimmer Biomet was $1,959,400,000.00 in 2016. The total inventory for Zimmer Biomet was $1,193,300,000.00 in 2014. The total inventory for Zimmer Biomet was $1,074,500,000.00 in 2014. The sales, general, and administrative (SGA) for Zimmer Biomet was $3,379,300,000.00 in 2018. The sales, general, and administrative (SGA) for Zimmer Biomet was $3,343,800,000.00 in 2019. The sales, general, and administrative (SGA) for Zimmer Biomet was $3,104,700,000.00 in 2017. The sales, general, and administrative (SGA) for Zimmer Biomet was $2,944,600,000.00 in 2016. The sales, general, and administrative (SGA) for Zimmer Biomet was $2,843,400,000.00 in 2021. The sales, general, and administrative (SGA) for Zimmer Biomet was $2,712,700,000.00 in 2020. The sales, general, and administrative (SGA) for Zimmer Biomet was $2,660,500,000.00 in 2015. The sales, general, and administrative (SGA) for Zimmer Biomet was $1,978,200,000.00 in 2014. The sales, general, and administrative (SGA) for Zimmer Biomet was $1,882,400,000.00 in 2013. The sales, general, and administrative (SGA) for Zimmer Biomet was $0.00 in 2014. The sales, general, and administrative (SGA) for Zimmer Biomet was $$2,762,000,000 in 2022. The revenue volatility for Zimmer Biomet was 9.87% in 2022. The market capitalization for Zimmer Biomet was $33,563,134,000.00 in 2013. The market capitalization for Zimmer Biomet was $30,574,604,000.00 in 2014. The market capitalization for Zimmer Biomet was $30,401,280,000.00 in 2020. The market capitalization for Zimmer Biomet was $26,938,200,000.00 in 2019. The market capitalization for Zimmer Biomet was $26,807,840,000.00 in 2015. The market capitalization for Zimmer Biomet was $26,756,179,980.00 in 2018. The market capitalization for Zimmer Biomet was $26,551,360,000.00 in 2014. The market capitalization for Zimmer Biomet was $23,449,955,117.00 in 2021. The market capitalization for Zimmer Biomet was $22,020,576,000.00 in 2016. The market capitalization for Zimmer Biomet was $21,934,590,000.00 in 2017. The market capitalization for Zimmer Biomet was $$25,487,000,000 in 2022. The gross revenue for Zimmer Biomet was $7,982,200,000.00 in 2019. The gross revenue for Zimmer Biomet was $7,932,900,000.00 in 2018. The gross revenue for Zimmer Biomet was $7,803,300,000.00 in 2017. The gross revenue for Zimmer Biomet was $7,668,400,000.00 in 2016. The gross revenue for Zimmer Biomet was $6,827,300,000.00 in 2021. The gross revenue for Zimmer Biomet was $6,127,500,000.00 in 2020. The gross revenue for Zimmer Biomet was $5,997,800,000.00 in 2015. The gross revenue for Zimmer Biomet was $4,673,300,000.00 in 2014. The gross revenue for Zimmer Biomet was $4,623,400,000.00 in 2013. The gross revenue for Zimmer Biomet was $0.00 in 2014. The gross revenue for Zimmer Biomet was $$6,940,000,000 in 2022. The gross margin for Zimmer Biomet was $17.18% in 2022. The days sales outstanding for Zimmer Biomet was 69 days in 2022. The days payable outstanding for Zimmer Biomet was 60 days in 2022. The days of inventory for Zimmer Biomet was $388 in 2022. The cost of goods sold (COGS) for Zimmer Biomet was 29.10% in 2022. The cost of goods sold (COGS) for Zimmer Biomet was $2,381,800,000.00 in 2016. The cost of goods sold (COGS) for Zimmer Biomet was $2,271,900,000.00 in 2018. The cost of goods sold (COGS) for Zimmer Biomet was $2,252,600,000.00 in 2019. The cost of goods sold (COGS) for Zimmer Biomet was $2,132,900,000.00 in 2017. The cost of goods sold (COGS) for Zimmer Biomet was $1,960,400,000.00 in 2021. The cost of goods sold (COGS) for Zimmer Biomet was $1,824,300,000.00 in 2020. The cost of goods sold (COGS) for Zimmer Biomet was $1,800,600,000.00 in 2015. The cost of goods sold (COGS) for Zimmer Biomet was $1,266,700,000.00 in 2013. The cost of goods sold (COGS) for Zimmer Biomet was $1,242,800,000.00 in 2014. The cost of goods sold (COGS) for Zimmer Biomet was $0.00 in 2014. The cost of goods sold (COGS) for Zimmer Biomet was $$2,019,000,000 in 2022. The cash to cash cycle time for Zimmer Biomet was 397 in 2022. The annual percentage growth rate of Zimmer Biomet was -0.02% in 2022. 94 days was the measured superior or top ten performance level for days of inventory in Zimmer Biomet's peer group in 2022. 9.89% was the measured superior or top ten performance level for sales volatility in Zimmer Biomet's peer group in 2022. 75 days was the measured superior or top ten performance level for cash to cash cycle time in Zimmer Biomet's peer group in 2022. 60 days was the measured parity or middle performance level for days sales outstanding in Zimmer Biomet's peer group in 2022. 53 days was the measured advantage or top third performance level for days sales outstanding in Zimmer Biomet's peer group in 2022. 44 days was the measured superior or top ten performance level for days sales outstanding in Zimmer Biomet's peer group in 2022. 37.24% was the measured parity or middle performance level for cost of goods sold as a percent of revenue in Zimmer Biomet's peer group in 2022. 31.56% was the measured advantage or top third performance level for cost of goods sold as a percent of revenue in Zimmer Biomet's peer group in 2022. 30.00% was the measured superior or top ten performance level for gross margin in Zimmer Biomet's peer group in 2022. 29.10% was the measured superior or top ten performance level for cost of goods sold as a percent of revenue in Zimmer Biomet's peer group in 2022. 159 days was the measured parity or middle performance level for days of inventory in Zimmer Biomet's peer group in 2022. 138 days was the measured parity or middle performance level for cash to cash cycle time in Zimmer Biomet's peer group in 2022. 13.32% was the measured parity or middle performance level for sales volatility in Zimmer Biomet's peer group in 2022. 119 days was the measured advantage or top third performance level for cash to cash cycle time in Zimmer Biomet's peer group in 2022. 11.40% was the measured advantage or top third performance level for sales volatility in Zimmer Biomet's peer group in 2022. 108 days was the measured advantage or top third performance level for days of inventory in Zimmer Biomet's peer group in 2022. 0.04% was the measured superior or top ten performance level for sales growth in Zimmer Biomet's peer group in 2022. -0.05% was the measured parity or middle performance level for sales growth in Zimmer Biomet's peer group in 2022. -0.02% was the measured advantage or top third performance level for sales growth in Zimmer Biomet's peer group in 2022. $18.02% was the measured advantage or top third performance level for gross margin in Zimmer Biomet's peer group in 2022. $17.18% was the measured parity or middle performance level for gross margin in Zimmer Biomet's peer group in 2022. $$6,940,000,000 was the measured advantage or top third performance level for gross revenue in Zimmer Biomet's peer group. $$3,735,000,000 was the measured parity or middle performance level for gross revenue in Zimmer Biomet's peer group in 2022. $$18,449,000,000 was the measured superior or top ten performance level for gross revenue in Zimmer Biomet's peer group in 2022.